Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 519-521

  Mazzaferro, V ^a   Regalia, E ^a   Pulvirenti, A ^a   Tagger, A ^b   Andreola, S ^a   Pasquali, M ^a   Baratti, D ^a   Romano, F ^a   Palazzo, U ^c   Zuin, M ^b   Bonino, F ^d   Ribero, M L ^b   Gennari, L ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERFERON; RIBAVIRIN;

CHRONIC HEPATITIS; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS GENOME;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2B; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; RIBAVIRIN; RNA, VIRAL; SURVIVAL RATE; TIME FACTORS;

EID: 12644310339     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00248-5     Document Type: Conference Paper

References (9)

1. Di Bisceglie AM: Hepatology 22:660, 1995
2. Wright TL, Donegan E, Hsu HH, et al: Gastroenterology 103:317, 1992
3. Konig V, Bauditz J, Lobeck H, et al: Hepatology 16:1137, 1992
4. Gane EJ, Portmann BC, Naoumov NV et al: New Engl J Med 334:815, 1996
5. Mazzaferro V, Regalia E, Doci R, et al: New Engl J Med 334:693, 1996
6. Desmet VJ, Gerber M, Hoofnagle JH, et al: Hepatology 19:1513, 1994
7. Knodell RG, Ishak KG, Black WC, et al: Hepatology 1:431, 1981
8. Feray C, Samuel D, Gigou M et al: Hepatology 22:1084, 1995
9. Cattral MS, Krajden M, Walness IR, et al: Transplantation 61:1483, 1996